ATE142690T1 - Methoden zur verhinderung von viralen replikationen - Google Patents

Methoden zur verhinderung von viralen replikationen

Info

Publication number
ATE142690T1
ATE142690T1 AT91909315T AT91909315T ATE142690T1 AT E142690 T1 ATE142690 T1 AT E142690T1 AT 91909315 T AT91909315 T AT 91909315T AT 91909315 T AT91909315 T AT 91909315T AT E142690 T1 ATE142690 T1 AT E142690T1
Authority
AT
Austria
Prior art keywords
methods
preventing viral
viral replications
replication
viral
Prior art date
Application number
AT91909315T
Other languages
English (en)
Inventor
Hubert E Blum
Tsanyang Liang
Eithan Galun
Jack R Wands
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24034871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE142690(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE142690T1 publication Critical patent/ATE142690T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cookers (AREA)
  • Cold Cathode And The Manufacture (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT91909315T 1990-04-20 1991-04-22 Methoden zur verhinderung von viralen replikationen ATE142690T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51142890A 1990-04-20 1990-04-20

Publications (1)

Publication Number Publication Date
ATE142690T1 true ATE142690T1 (de) 1996-09-15

Family

ID=24034871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909315T ATE142690T1 (de) 1990-04-20 1991-04-22 Methoden zur verhinderung von viralen replikationen

Country Status (10)

Country Link
EP (1) EP0528903B1 (de)
JP (1) JPH05506993A (de)
AT (1) ATE142690T1 (de)
AU (1) AU656136B2 (de)
CA (1) CA2081022A1 (de)
DE (1) DE69122098T2 (de)
DK (1) DK0528903T3 (de)
ES (1) ES2091928T3 (de)
GR (1) GR3021656T3 (de)
WO (1) WO1991016420A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596132A (en) * 1990-03-12 1997-01-21 Cornell Research Foundation, Inc. Induction of resistance to virus diseases by transformation of plants with a portion of a plant virus genome involving a read-through replicase gene
US5633449A (en) * 1990-03-12 1997-05-27 Cornell Research Foundation, Inc. Induction of resistance to viral diseases in plants
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
GB9208545D0 (en) * 1992-04-21 1992-06-03 Gatsby Charitable Foundation T Virus resistant plants
WO1993025068A1 (en) * 1992-06-08 1993-12-23 Cornell Research Foundation, Inc. Viral resistance by plant transformation with a replicase portion of a plant virus genome
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
DE19517532C2 (de) * 1995-05-12 1999-10-28 Max Planck Gesellschaft HBV-Vektoren und Zellen zu ihrer Bereitstellung
CN100412190C (zh) * 2001-03-15 2008-08-20 复旦大学 乙肝病毒全基因组多聚酶嵌合体的组建方法和应用
CN102643858B (zh) * 2011-02-16 2014-04-02 复旦大学 一种高效复制的人乙型肝炎病毒重组载体及其应用
MX347253B (es) 2011-04-21 2017-04-20 Ionis Pharmaceuticals Inc Modulación de la expresión del virus de hepatitis b (vhb).

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477994B1 (de) * 1985-03-21 2001-06-13 Johnston, Stephen, Ph.D. Von Parasit gewonnener Widerstand
EP0380656A1 (de) * 1988-08-16 1990-08-08 Yale University Defiziente hepadna-viren, produktive zellinie für impfstoffe sowie behandlung von erkrankungen und störungen der leber
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.

Also Published As

Publication number Publication date
EP0528903B1 (de) 1996-09-11
CA2081022A1 (en) 1991-10-21
DE69122098T2 (de) 1997-02-20
ES2091928T3 (es) 1996-11-16
DK0528903T3 (da) 1996-09-30
DE69122098D1 (de) 1996-10-17
AU656136B2 (en) 1995-01-27
AU7785891A (en) 1991-11-11
GR3021656T3 (en) 1997-02-28
WO1991016420A1 (en) 1991-10-31
EP0528903A4 (en) 1993-09-08
EP0528903A1 (de) 1993-03-03
JPH05506993A (ja) 1993-10-14

Similar Documents

Publication Publication Date Title
ATE142690T1 (de) Methoden zur verhinderung von viralen replikationen
DK1121135T3 (da) Præparater af beta-glucaner og specifikke immunglobuliner
ATE107715T1 (de) Zusammensetzung in form einer wässrigen dispersion und verfahren zur behandlung von fasermaterialien.
DE3751923D1 (de) Verfahren zur Klonierung von Restriktions-Modifikationssystemen
PT626998E (pt) "producao de plantas resistentes aos virus, mediante introducao de uma molecula de arn viral nao traduzivel e de sentido codificador"
DE69424522D1 (de) Methode zur resuspendierung von zellreichen konzentraten
NO963860L (no) Isoprenyl-transferase-inhibitorer
AU6125296A (en) Oligonucleotides specific for hepatitis b virus
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
DE69432351D1 (de) Verfahren zum sterilisieren von produkten
DE3680130D1 (de) Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.
DE59308857D1 (de) Verfahren zur Beseitigung von Schadstoffen, insbesondere im Erdbodenbereich
DE69622413D1 (de) Zusammensetzbares spielgerät,insbesondere zur herstellung von rollbahnen
DE3787515D1 (de) Verfahren zur On-Line-Vorausberechnung und -Kontrolle von alkoholischen Gärungen.
ATE173466T1 (de) Verbindungen und methoden zur inhibition von hiv und verwandten viren
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
PT98565A (pt) Um processo de producao de uma composicao para o tratamento da infeccao por hsv
EP0569703A3 (de) Verfahren zur Behandlung und Verhütung viraler Infektionen unter Verwendung von HBNF und MK Protein.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
DE69230643D1 (de) Methode zur behandlung von viralen infektionen
DE69201136D1 (de) Typ II Restriktionsendonuklease von Arthrobacter Species und Verfahren zu seiner Herstellung.
WO1996039500A3 (en) Oligonucleotides specific for hepatitis c virus
FI965114A7 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
ATE178654T1 (de) Impstoff zum schutze von pferden gegen pferdeherpesvirus-infektionen
DE69330246D1 (de) Impfstoffe auf der basis von streptokinase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked